** Shares of some U.S. drugmakers fall premarket, amid a broader market sell-off, after U.S. President Donald Trump threatened steep tariffs on the sector
** The pharma sector had briefly ducked Trump's sweeping tariffs announcement on Wednesday, but some of the stocks have wiped off gains from the previous session after he said the sector was under review
** Shares of Merck MRK.N down 1.6%, Biogen BIIB.O down 1.3%, Pfizer PFE.N down 2% and Eli Lilly LLY.N down 3% before the bell
** MRK, AbbVie ABBV.N and Amgen AMGN.O climbed between 2% and 3% on Thursday
** Up to last close, LLY up 2.2% , MRK down 13.2%, BIIB down 14.5% and PFE down 8.4% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。